AAAAAA

   
Results: 1-2 |
Results: 2
INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP
Authors: KEILHOLZ U GOEY SH PUNT CJA PROEBSTLE TM SALZMANN R SCHEIBENBOGEN C SCHADENDORF D LIENARD D ENK A DUMMER R HANTICH B GEUEKE AM EGGERMONT AMM
Citation: U. Keilholz et al., INTERFERON ALFA-2A AND INTERLEUKIN-2 WITH OR WITHOUT CISPLATIN IN METASTATIC MELANOMA - A RANDOMIZED TRIAL OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER MELANOMA COOPERATIVE GROUP, Journal of clinical oncology, 15(7), 1997, pp. 2579-2588
ADDITION OF DACARBAZINE OR CISPLATIN TO INTERFERON-ALPHA INTERLEUKIN-2 IN METASTATIC MELANOMA - TOXICITY AND IMMUNOLOGICAL EFFECTS
Authors: KEILHOLZ U SCHEIBENBOGEN C MOHLER T BROSSART P MACLACHLAN D GEUEKE AM JOCHIM A HUNSTEIN W
Citation: U. Keilholz et al., ADDITION OF DACARBAZINE OR CISPLATIN TO INTERFERON-ALPHA INTERLEUKIN-2 IN METASTATIC MELANOMA - TOXICITY AND IMMUNOLOGICAL EFFECTS, Melanoma research, 5(4), 1995, pp. 283-287
Risultati: 1-2 |